Research Grants and Patents

Innovator in Surgical Research

Dr. Craft has also contributed to scientific innovation through research grants and intellectual property:

• Research Grants: As Principal Investigator, Dr. Craft led a funded study at St. Vincent’s Institute (Melbourne) examining the “Effect of human Adenovirus-36 in a localized in vivo model of neoadipogenesis” (ROC CV 2025.docx). This grant-supported research explored how a human virus strain might stimulate new fat tissue formation – a novel idea in regenerative medicine at the time. (Mentorship for this project was through the O’Brien Institute, highlighting international collaboration.)
• Patents / Intellectual Property: Dr. Craft developed a technique for “local, long-term delivery of PDGF on injected fat-graft survival,” which was patented/provisionally patented during his fellowship in Australia (ROC CV 2025.docx). This invention aimed to improve fat graft viability using growth factor-releasing microspheres, and the positive results were published in JPRAS (Effect of local, long-term delivery of platelet-derived growth factor (PDGF) on injected fat graft survival in severe combined immunodeficient (SCID) mice - PubMed). (While the full patent details may not be publicly listed in USPTO, its concept and efficacy are documented in literature.)
• Clinical Innovation: In addition to formal patents, Dr. Craft has been involved in clinical technique innovations (e.g., a novel method for securing ventriculoperitoneal shunt tubing laparoscopically (ROC CV 2025.docx), and improvements in flap surgery as noted in publications). These advancements exemplify his hands-on contributions to surgical technology and techniques.